Recombinant DNA Technology Market Overview 2019 to 2023 report published by “Market Research Future”. According to report Global Recombinant DNA Technology Market to Grow At 6.9% CAGR by 2023. Recombinant DNA Technology Market Research report Covered Information by Product (Medical, Non-Medical), Component (Expression System, Cloning Vector), Application (Food & Agriculture, Health & Disease), End-User (Biotechnology Companies, Pharmaceuticals) – Forecast to 2023.
Some of the key players in the global recombinant DNA technology market are F. Hoffmann-La Roche Ltd (Switzerland), Profacgen (U.S.), Amgen Inc. (U.S.), Novartis AG (Switzerland), Genscript Biotech (U.S.), Pfizer Inc. (U.S.), Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Sanofi S.A. (France), Merck & Co., Inc. (U.S.), Biogen Inc. (U.S.), Biocon Limited (India), GlaxoSmithKline plc (UK), New England Biolabs (U.S.), Cibus (U.S.), Monsanto Company (U.S.), Horizon Discovery Group PLC (U.S.), Boehringer Ingelheim (Germany), and others.
Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5845
Recombinant DNA Technology Market t is proposed to expand at a CAGR of approximately 6.9 percent over the forecast period. The breakthroughs in genetic research have opened up new avenues for the development of recombinant DNA technology. Market reports connected with the healthcare industry have been made accessible by Market Research Future who publishes reports on other sectors that have been recently put out along with a report on this industry.
As the domain of genetics had been relatively unchartered due to lack of proper expertise and technology, the presence of these factors in abundance currently is fostering optimistic market growth. Development of topnotch research laboratories worldwide is adding impetus to the progress of the market. Rising focus on function, gene structure, expression pattern, and regulation are forecasted to add to the market expansion over the forecast period beneficially.
The global recombinant DNA technology market is segmented on the basis of product, component, application, and end-user.
On the basis of product, the global recombinant DNA technology market is segmented into medical, non-medical, and others. The medical segment is divided into therapeutic agent, human protein, and vaccines. The non-medical segment is divided into biotech crops, specialty chemicals, and others.
On the basis of component, the global recombinant DNA technology market is segmented into expression system, cloning vector, and others. The expression system segment is divided into mammalian, bacteria, yeast, baculovirus/insect, and others. The cloning vector segment is divided into plasmid, phage, cosmid, Bacterial Artificial Chromosome (BAC), Yeast Artificial Chromosome (YAC), and Human Artificial Chromosome (HAC).
On the basis of application, the global recombinant DNA technology market is segmented into food and agriculture, health and disease, environment, and others.
On the basis of end-user, the global recombinant DNA technology market is segmented into biotechnology companies, academic and government research institutes, pharmaceuticals, and others.
The global recombinant DNA technology market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas region holds the largest market share of the global recombinant DNA technology market due to the presence of effective regulations pertaining to the approval of recombinant therapeutics and other Genetically Modified (GM) products. F. Hoffmann-La Roche Ltd, Amgen Inc., Novartis AG, Monsanto Company, Eli Lilly and Company, and Biogen Inc. are some of the major companies operating in this space that are responsible for the growth of the Americas recombinant DNA technology market.
Furthermore, there is an increasing need to improve the recombinant proteins production capacity by several folds in Europe. The increase in demand for effective therapeutics for the treatment of diseases and technological advancements in this sector are anticipated to drive the growth of the European recombinant DNA technology market.
Asia Pacific is expected to emerge as the fastest growing regional market for the global recombinant DNA technology market. The increasing awareness about the growing genetic diseases and disorders, developing healthcare infrastructure, increasing spending on healthcare, increasing government initiatives to improve public health, and advances in medical fields are driving the market growth.
The Middle East and Africa is expected to experience a limited growth due to less demand for genetic testing. The Middle East is growing significantly as compared to the African recombinant DNA technology market owing to the increase in aging population, innovations in genetic testing, and increase in the number of chronic disease cases.
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
LIST OF TABLES:
Table 1 Recombinant DNA Technology Industry Synopsis, 2017–2023
Table 2 Recombinant DNA Technology Market Estimates & Forecast, 2017–2023, (USD Million)
Table 3 Recombinant DNA Technology Market, By Region, 2017–2023, (USD Million)
Table 4 Recombinant DNA Technology Market, By Product, 2017–2023, (USD Million)
Table 5 Recombinant DNA Technology Market, By Component, 2017–2023, (USD Million)
Table 6 Recombinant DNA Technology Market, By Application, 2017–2023, (USD Million)
Table 7 Recombinant DNA Technology Market, By End-U.S.Er, 2017–2023, (USD Million)
Table 8 North America Recombinant DNA Technology Market, By Product, 2017–2023, (USD Million)
Table 9 North America Recombinant DNA Technology Market, By Component, 2017–2023, (USD Million)
Table 10 North America Recombinant DNA Technology Market, By Application, 2017–2023, (USD Million)
Browse More Information On This Report at https://www.marketresearchfuture.com/reports/recombinant-dna-technology-market-5845
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Magarpatta Road, Hadapsar
Pune – 411028
Maharashtra, India+1 646 845 9312